[Induction of lymphokine-activated killer (LAK) cells from tumor-bearer splenocytes and their utilization in inhibition of tumor metastasis].
D000818:Animals; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D005260:Female; D007376:Interleukin-2 / Q000276:immunology*; D007694:Killer Cells, Natural / Q000637:transplantation*; D007942:Leukemia, Experimental / Q000628:therapy; D008114:Liver Neoplasms, Experimental / Q000628:therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000628:therapy*; D013154:Spleen / Q000166:cytology
D007376:Interleukin-2